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 Abstract 
Background: Alzheimer’s disease (AD) has become a concerning public health issue. 
We aimed to analyse the trends of hospital morbidity from AD in the European Union 
(EU) in the period 2000-2014. Methods: Data from hospital discharges of men and 
women over 50 years old hospitalised from AD in the EU were extracted from Eurostat 
database. We tested for secular trends computing the annual percent change, and 
identifying significant changes in the linear slope of the trend. Results: Hospital 
morbidity from AD showed a 0.8% (95% confidence intervals -2.2, 0.6) slight declining 
trend in the EU. In men and women, we recorded a -0.5% and -1.0% decrease in hospital 
morbidity rates, respectively. Several countries showed changing trends during the study 
period. Conclusion: AD hospital morbidity has slightly declined in the entire EU in the 
past years. Eastern European countries showed steadily increasing trends, whereas in 
western and Mediterranean countries rates decreased or levelled off. 
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 Introduction 
Alzheimer’s disease (AD) is the most common type of dementia, accounting for 60-
70% of all cases.1 In 2015, almost 47 million people worldwide suffered from dementia, 
and this figure could reach 131 million by 2050. Among them, the number of patients in 
Europe is estimated to rise from 10.46 million in 2015 to almost 19 million in 2050.2 
Several studies have studied the epidemiology of AD in different world regions. In 
European countries, a meta-analysis estimated that the overall prevalence and incidence 
in people older than 55 years were 5.05%, and 11.08 per 1000 person-years, respectively,3 
and mortality has increased in the past decades.4 In the United States, prevalence of the 
disease was 9.51%,5 while in developing countries was estimated to be 3.4%.6 
Patients with AD live several years from the onset of the disease,7 and are at higher 
risk for hospitalisation.8 Therefore, AD lead to a great societal and economic burden. In 
Europe, in 2010 the total costs of dementia reached 238 billion dollars, of which direct 
medical costs accounted for 36 billion dollars,9 whilst total payments for health care, long-
term care and hospice for patients with AD and other dementias in the United States were 
estimated at 236 billion dollars.10 
Despite the well-known impact of AD, to date, there is a lack of research regarding 
the trends of hospital morbidity from the disease, probably given its role of underlying, 
but not main condition, for hospitalisation in many cases. Therefore, we aimed to analyse 
the trends of hospital morbidity from AD in the European Union (EU) in the period 2000-
2014. Our findings may reflect the trajectories of hospitalisations from the disease in 
European countries in the past years, thus providing new evidence essential for planning 
public health policies. 
Methods 
Data from hospital discharges, defined as formal release of a patient from a hospital, 
including patients discharged alive, dead or transferred to another hospital,11 of men and 
women over 50 years old hospitalised from AD (defined as the main condition determined 
 as principal cause of the episode of hospitalisation) for a minimum of one night or more 
than 24 hours (in-patient) or discharged on the same day (day-cases) in the member 
countries of the EU. We extracted data from Eurostat, the statistical office of the EU, for 
the period 2000-2014 due to the availability of the data for most of European countries in 
these years.12 Eurostat receives data from each country’s statistical authorities, checks the 
comparability of the data and ensures the internal coherence by annual validation 
processes. 
Diagnosis for hospital discharges were coded using the International Shortlist for 
Hospital Morbidity Tabulation (ISHMT).13 Code 0601 (Alzheimer’s disease, 
International Classification of Diseases (ICD) 9th and 10th revision codes 331.0 and G30, 
respectively) was used. 
To broaden the focus of the study, we conducted an additional analysis of men and 
women over 50 years old hospitalised from dementia. Diagnosis for hospital discharges 
were coded with ICD codes F00-F03.12 
Estimates of resident population, based on official censuses, were also extracted 
from the Eurostat database.14 
The EU member countries and their data availability included: Austria (2000-
2014), Belgium (2000-2009, 2011-2013), Croatia (2002-2014), Cyprus (2005-2007, 
2010-2013), Czech Republic (2000-2014), Denmark (2000-2014), Finland (2001-2014), 
France (2000-2014), Germany (2000-2014), Hungary (2004-2014), Ireland (2000-2014), 
Italy (2001-2014), Latvia (2004-2014), Lithuania (2001-2014), Luxembourg (2002-
2014), the Netherlands (2004-2012), Poland (2005-2014), Portugal (2000-2014), 
Slovakia (2000-2012, 2014), Slovenia (2004-2014), Spain (2000-2014), and the United 
Kingdom (2000-2014). 
Unfortunately, for several countries (Bulgaria, Greece, Estonia, Malta, Romania 
and Sweden) most of the data were not available, and were excluded from the study. In 
addition, in a few countries data for one or more calendar years were missing. No 
 extrapolation was made for missing data, assuming trends would not vary substantially 
in countries with less missing data, whereas in countries with more missing data, results 
should be interpreted carefully. 
From the number of hospitalisations and resident population, age-standardised 
hospital morbidity rates per 100,000 for each 5-year age group (from 50-54 to 85 and 
older) and calendar period for men and women were computed, using the direct method 
and based on the 2013 European Standard Population. Some countries (Czech Republic, 
Denmark, Italy and Slovenia, these two latter countries only for day-cases) considered 
multi-episodes cases as one hospital discharge, while the remaining countries considered 
them as separate discharge records, or do not allude to this issue.11 
Joinpoint regression software (version 4.2.0.2), provided by the Surveillance 
Research Program of the USA National Cancer Institute (Bethesda, MD, USA), was used 
to analyse significant changes in morbidity trends. This analysis identifies inflexion 
points (joinpoints) at which there was a significant change in the linear slope of the 
trend.15 
We computed the estimated annual percent change (APC) and corresponding 95% 
confidence intervals (95% CIs), describing the magnitude of change of the identified 
trends. In this model, age-standardised morbidity rates were used as the dependent 
variable, and the year of hospital discharge as the independent variable. A p value lower 
than 0.05 was considered as statistically significant. No approval by an institutional 
review board was required. 
Results 
Trends of hospital morbidity from Alzheimer’s disease 
Between 2000 and 2014, the number of hospital discharges of in-patients and day-
cases over 50 years old hospitalised by AD in the EU increased from 38,428 to 59,937. 
Throughout the study period, among the member states of the EU, the highest 
 hospital morbidity rates were found in Finland, Belgium and Austria, whereas Cyprus, 
Latvia, Denmark and Portugal showed the lowest rates. The highest overall age-
standardised morbidity rate was observed in Finland in 2007, 329.7 per 100,000, and in 
Latvia we found the lowest, 0.7 per 100,000, in the year 2006. (Supplemental Data 1) 
During the 2000-2014 period, the entire EU showed a slight non-significant 
downward trend (APC=-0.8%; 95% CI -2.2, 0.6), identifying two joinpoints. Between 
2000 and 2004, hospital morbidity rates showed a statistically significant rising trend 
(APC=6.6%; 95% CI 2.2, 11.1), followed by a significant decrease in the period 2004-
2012 (APC=-1.8%; 95% CI -3.5, -0.1), and a non-significant pronounced downward trend 
thereafter (APC=-11.4%; 95% CI -22.4, 1.2). 
Morbidity rates increased in 12 countries throughout the EU. The Netherlands, 
Latvia and Spain showed the largest growths, whereas Finland and Germany had the less 
pronounced increases. On the contrary, the remaining 10 countries showed overall 
downward trends, recording in France, Luxembourg, and Italy the steepest declines, 
whilst in Hungary and Portugal morbidity rates descended slightly. (Table 1) 
Trends of hospital morbidity from Alzheimer’s disease in men 
In 2000, the highest rates in men were recorded in France, Belgium and Czech 
Republic (over 50 per 100,000), while Spain, Slovakia, Denmark, and Portugal showed 
the lowest (below 8 per 100,000). In 2014, we observed the highest rates in Finland, 
Czech Republic and Slovenia (over 80 per 100,000), and the lowest in Denmark, Portugal 
and Latvia (below 9 per 100,000). (Supplemental Data 2) 
Along the study period, European men showed an overall non-significant downward 
trend in hospital morbidity (APC=-0.5%; 95% CI -1.8, 0.8), identifying two joinpoints. 
In the first years, a statistically significant growing trend was recorded, followed by non-
significant decreasing trends afterwards, more pronounced in the latter years. 
Morbidity rates rose in 13 countries. The Netherlands, Latvia and Spain showed the 
steepest increasing trends, while in Cyprus, Hungary and Finland the less pronounced 
 growing trends were observed. Conversely, in 9 countries rates lessened over the study 
period. In France, Italy and Luxembourg we recorded the largest declining trends, whilst 
in Portugal, Austria, Croatia and the United Kingdom we found the less pronounced 
decreases. (Table 2) 
In Austria, Denmark, Finland, France and Poland, APC peaked, decreasing 
thereafter. Hospital morbidity rates in Italy increased at a lower rate in the first years, 
almost levelling off, significantly descending afterwards. In Germany and Spain, after a 
significant increasing trend in the first period, rates continued growing at a lower rate, in 
contrast to the Netherlands, where rose sharply in the last years. In Czech Republic and 
Slovakia fluctuating trends were observed. 
Trends of hospital morbidity from Alzheimer’s disease in women 
For European women, in 2000 we found the highest rates in France, Belgium and 
Czech Republic (over 60 per 100,000), and the lowest in Spain, Slovakia, Portugal and 
Denmark (below 6 per 100,000). In 2014, the highest rates were recorded in Finland, 
Czech Republic and Slovenia (over 80 per 100,000), and the lowest in Denmark and 
Portugal (below 7 per 100,000). (Supplemental Data 3) 
Likewise, among women, an overall non-significant downward trend was recorded 
(APC=-1.0%; 95% CI -2.4; 0.5), identifying two joinpoints. We observed a significant 
growing trend in the first years, followed by a significant decrease, and a more 
pronounced non-significant declining trend in the latter years. 
During the study period, 13 countries showed an upward trend. The Netherlands, 
Latvia and Spain showed the steepest growths, while in Finland, Germany and Portugal 
rates increased slightly or almost levelled off. In contrast, 9 countries showed declining 
trends. France, Luxembourg and Croatia had the largest decreases, whilst Austria, 
Denmark and Hungary showed the less pronounced declines. (Table 3) 
In Austria, Denmark, Finland, France, Germany, Italy and Poland, APCs peaked, 
declining thereafter. In two countries (Lithuania and Slovenia), significant pronounced 
 upward trends were recorded in the first period, significantly increasing at a lower rate 
afterwards, contrasting with the pronounced growing trend found in the Netherlands in 
the latter years. In Croatia and Hungary morbidity rates lowered in the first period, 
showing a non-significant rising in the latter. In Slovakia and Spain, fluctuating trends 
were observed. 
Trends of hospital morbidity by gender in the whole EU are shown in Figure 1. 
Except in Austria, Denmark, Finland, Germany, the Netherlands, Poland, Slovakia and 
Spain, trends were more pronounced in women than in men. Furthermore, in Hungary 
and Portugal, trends were divergent. (Figure 2) 
Trends of hospital morbidity from dementia 
Between 2000 and 2014, hospital morbidity rates from dementia showed a 
significant downward trend (APC=-3.9%; 95% CI -4.2, -3.7). We did not identify any 
joinpoints. 
Morbidity rates increased in 4 countries: Cyprus, Ireland, Latvia and Slovenia. In 
the first 3 countries, we recorded the largest increases (all statistically significant), 
especially in Cyprus. Conversely, the remaining countries showed overall declining 
trends. We found in Belgium, Germany, Italy and Lithuania the steepest decreases, whilst 
in Croatia, France and Slovakia morbidity rates declined slightly. (Supplemental Data 4-
6) 
Morbidity trends from AD and dementia showed the same direction in 12 countries 
(Austria, Croatia, Cyprus, Denmark, France, Hungary, Italy, Latvia, Luxembourg, 
Portugal, Slovenia and the United Kingdom), while in the remaining 10 countries 
(Belgium, Czech Republic, Finland, Germany, Ireland, Lithuania, the Netherlands, 
Poland, Slovakia and Spain) hospital morbidity trends were divergent. 
Discussion 
To the best of our knowledge, this is the first study analysing the trends in hospital 
 morbidity from AD in the EU according to hospital discharge data. Our results indicate 
that, despite the growing number of hospital discharges, trends declined slightly in both 
sexes along the past years. By countries, the steepest increases were found in the 
Netherlands, Latvia and Spain, whereas in France, Luxembourg and Italy we recorded the 
largest descending trends. 
Our results are in line with a US study which reported a slight decline of trends in 
hospitalisations between 1999 and 2009, describing an increasing trend in the first years, 
followed by a subsequent decrease.16 In other European studies, both prevalence of 
dementia in hospitalised population and hospitalisation rates tended to increase in the 
early 2000s, which also seem to be consistent with our findings.17,18 
This study retrieved data from 22 EU countries. Therefore, differences in diagnosis 
and hospital practice, discharge patterns and cultural differences within these countries, 
considered as inherent factors, might explain to a certain extent the divergences observed. 
In this line, in a previously published study, Waldemar et al.19 identified the economic 
barriers, including not only differences in per capita gross domestic product, but 
variations in care costs across European regions,20 the fear of social stigma and cultural 
beliefs and the lack of specialists as the main barriers affecting the access to diagnostic 
evaluation and treatment for the disease in EU. 
In the former-Soviet Baltic States and eastern European countries, where steady 
growing trends were recorded, improvement of social conditions, economic development, 
and the adoption of healthier lifestyle habits, which have led to the rise of life expectancy 
in the past decades,21 and therefore to rising prevalence of age-related diseases such as 
AD, might be a reason of the trends observed. Also, changes in the survival period among 
people who suffer the disease, with a prolonged survival of several years,22,23 might 
increase the probability to be hospitalised for this cause.  
Conversely, in most of the western and Mediterranean countries, after increasing in 
the first years, hospitalisation rates tended to decrease. Prior investigations have 
ascertained that prevalence of dementia have lessened in these countries,24 probably due 
 to societal changes that brought about better living conditions, and the progressive 
adherence to healthier lifestyles.25 Therefore, we speculate that the lowering in prevalence 
might be, to a certain extent, related to the descending trends observed in the latter years. 
Other related factor that may explain this decline is the considerable increase in utilization 
of ambulatory services and primary care services by patients diagnosed with AD,26,27 
especially among rural population.28 
In some countries, very pronounced upward trends were observed in the first study 
period. We propose several hypotheses for this observation. On the one hand, this could 
be the reflection of an increase awareness of the condition by the physicians, as reported 
in a Finnish study finding that predictive positive value for hospital discharge diagnoses 
improved considerably after 1998.29 On the other hand, methodological issues, e.g. in 
Austria, there was a change from ICD-9 to ICD-10 in year 200111 could explain the sharp 
increasing trend observed in this country. 
The fact that, despite recent efforts, AD is still underreported in hospital discharge 
registers, should also be mentioned. In a Swedish study testing two disease registries, 
sensitivity was 55%, thus missing 45% of prevalent patients in the inpatient registry.30 
More recently, Douzenis et al.31 also found that cognitive decline was greatly 
underdiagnosed. 
Other factor that may confuse AD diagnosis is the fact that some patients might 
suffer delirium during their hospital stay. Some investigations reported that prevalence of 
delirium in older patients ranged between 16% to 20%.32,33 Also, delirium appears to be 
phenomenologically similar among patients with or without dementia.34 This fact may 
lead to misdiagnose AD among non-dementia patients and should be taken into account. 
We could not use algorithms to validate AD diagnosis in this study and should be 
acknowledged. However, Eurostat conducts annual validation processes and consistency 
checks,11 thus we assume data used have sufficiency quality to ensure study’s validity.   
One of the reasons of this underreporting might be that most of the patients with AD 
were not admitted for the disease itself, but to co-morbid conditions.35 Comorbidities, 
 besides being independently associated with higher costs of care,36 also increased the risk 
of subsequent hospital admission and emergency department visit.37 In this line, Browne 
et al.38 found that the clear majority of patients with dementia had at least one comorbid 
condition, and reported that a higher number of comorbidities was related to increased 
primary care consultation rates and hospital admission rates. Other recent investigations 
also found that comorbidity burden of patients with dementia was heavier than non-
dementia patients.39 This fact difficult the recognition and correct diagnosis of AD by the 
physicians when a patient is admitted, consequently leading to underreport the real AD 
hospitalization. This underreport is reflected in our findings, where only those patients 
diagnosed with AD as the main cause of hospitalisation were included. Therefore, it seems 
reasonable to assume that the real hospital morbidity rate might be higher. 
Another issue that deserve discussion is that many of the elderly with AD might have 
been admitted to nursing homes. In institutionalised persons, probability of 
hospitalisation decreased as dementia worsened.40,41 However, this institutionalised 
population has not been considered in this study, as well as people treated at home. 
Therefore, it is plausible to think that we might have underestimated the real hospital 
morbidity rates. 
As expected, morbidity trends in women were more pronounced than in men in most 
of European countries, possibly due to their longer life expectancy,42 and biological and 
social factors.43 
Our study has several strengths. To our knowledge, this is a novel study analysing 
hospital morbidity trends in the whole of the EU. In addition, we decided to only use 
official data, and not extrapolate or impute any missing data, which ensure the validity of 
our results. However, this work also has some limitations. First, the lack of data from 
several years or the whole period in some countries, whose inclusion would have 
improved the validity and generalization of our results. Second, the use of ICD codes may 
influence diagnosis coding, leading to under-code the condition.44 This fact affects to 
some extent the validity of our data and should be taken into account. Another limitation 
 is the non-inclusion of institutionalised population, which could have led to underreport 
the real morbidity, and should be duly acknowledged. 
In summary, our findings confirmed a slight downward trend of hospital morbidity 
from AD in the EU, according to hospital discharge data, in the past years. Disparities 
among countries were observed, finding steady growing trends mainly in eastern 
European countries, whereas in most of western and Mediterranean countries hospital 
morbidity rates tended to decrease or almost levelled off, especially in the latter years. 
This novel approach in studying trajectories of hospitalisation from AD in the European 
Union provide new evidence for planning future public health policies in aged societies. 
The inclusion of institutionalised population, the effect of medical awareness and 
diagnostic improvements, and inclusion of secondary hospital diagnoses, deserve further 
studies. 
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 Table 1. Joinpoint analysis for Alzheimer’s disease hospital morbidity trends in the European Union, 2000-2014. 
 Total study period Period 1 Period 2 Period 3 
  Years APCa (95% CIb) Years APCa (95% CIb) Years APCa (95% CIb) Years APCa (95% CIb) 
European Union 2000-2014 -0.8 (-2.2, 0.6) 2000-2004 6.6* (2.2, 11.1) 2004-2012 -1,8* (-3.5 -0.1) 2012-2014 -11.4 (-22.4, 1.2) 
Austria 2000-2014 -1.4 (-6.8, 4.3) 2000-2002 104.8* (17.6, 256.8) 2002-2014 -6.8* (-9.8, -3.7) - - 
Belgium 2000-2013 10.4* (7.9, 12.9) - - - - - - 
Croatia 2002-2014 -4.5* (-7.6, -1.2) 2002-2012 -7.0* (-11.0, -2.9) 2012-2014 24.3 (-28.6, 116.6) - - 
Cyprus 2005-2013 9.1 (-1.6, 21.0) - - - - - - 
Czech Republic 2000-2014 4.4* (3.7, 5.2) - - - - - - 
Denmark 2000-2014 -2.1 (-5.0,0.9)  2000-2006 5.7* (1.6, 10.1) 2006-2012 -3.2 (-8.2, 2.1) 2012-2014 -30.4* (-45.2, -11.7) 
Finland 2001-2014 2.7* (1.4, 4.0) 2001-2007 7.5* (5.9, 9.2) 2007-2011 -2.2 (-6.6, 2.4) 2011-2014 2.2 (-2.4, 7.0) 
France 2000-2014 -7.0* (-10.2, -3.7) 2000-2007 3.4 (-1.7, 8.7) 2007-2014 -16.4* (-20.5, -12.1) - - 
Germany 2000-2014 3.1* (1.5, 4.7) 2000-2003 16.7* (11.3, 22.4) 2003-2007 3.1 (-1.7, 8.1) 2007-2014 -0.3 (-1.6, 0.9) 
Hungary 2004-2014 -0.2 (-4.5, 4.4) 2004-2008 -11.9 (-23.5, 1.6) 2008-2014 7.2 (-0.7, 15.6) - - 
Ireland 2000-2014 -3.4* (-5.0, -1.7) - - - - - - 
Italy 2001-2014 -5.0* (-6.8, -3.1) 2001-2005 1.4 (-1.1, 3.8) 2005-2009 -2.6 (-6.3, 1.2) 2009-2014 -11.9* (-13.4, -10.4) 
Latvia 2004-2014 18.7* (4.4, 34.9) - - - - - - 
Lithuania 2001-2014 9.8* (7.1, 12.6) 2001-2004 28.3* (13.0, 45.7) 2004-2014 6.8* (4.7, 8.9) - - 
Luxembourg 2002-2014 -5.3* (-7.3, -3.2) - - - - - - 
Netherlands 2004-2012 27.5* (13.1, 43.8) 2004-2010 13.3* (9.5, 17.3) 2010-2012 115.5* (75.6, 164.5) - - 
Poland 2005-2014 5.4 (-6.6, 18.8) 2005-2012 19.4* (10.1, 29.4) 2012-2014 -47.6* (-71.3, -4.3) - - 
Portugal 2000-2014 -0.6 (-1.9, 0.9) - - - - - - 
Slovakia 2000-2014 5.2* (0.8, 9.7) 2000-2004 37.2* (21.1, 55.4) 2004-2008 -13.1 (-28.7, 5.9) 2008-2014 9.6* (1.9, 17.8) 
Slovenia 2004-2014 8.9* (6.1, 11.8) 2004-2006 28.4* (2.4, 60.9) 2006-2014 6.4* (3.8, 9.0) - - 
Spain 2000-2014 17.1* (9.4, 25.3) 2000-2005 57.6* (26.8, 95.9) 2005-2014 2.9 (-5.9, 12.5) - - 
United Kingdom 2000-2014 -2.4* (-3.2, -1.7) - - - - - - 
Abbreviations: APC: annual percent change; CI: confidence interval. *p-value<0.05 for change in trend.  
 Table 2. Joinpoint analysis for Alzheimer’s disease hospital morbidity trends in men in the European Union, 2000-2014. 
 Total study period Period 1 Period 2 Period 3 
  Years APCa (95% CIb) Years APCa (95% CIb) Years APCa (95% CIb) Years APCa (95% CIb) 
European Union 2000-2014 -0.5 (-1.8, 0.8) 2000-2004 6.4* (2.1, 10.9) 2004-2012 -1.4 (-3.2, 0.3) 2012-2014 -10.2 (-21.3, 2.4) 
Austria 2000-2014 -1.7 (-7.4, 4.2) 2000-2002 92.8* (55.7, 138.7) 2002-2009 -1.5 (-5.0, 2.2) 2009-2014 -16.6* (-20.5, -12.6) 
Belgium 2000-2013 9.4* (7.0, 11.9) - - - - - - 
Croatia 2002-2014 -1.9 (-6.0, 2.4) - - - - - - 
Cyprus 2005-2013 1.8 (-14.2, 20.9) - - - - - - 
Czech Republic 2000-2014 4.3* (3.3, 5.4) 2000-2004 5.4* (0.3, 10.7) 2004-2007 -1.9 (-16.1, 14.6) 2007-2014 7.6* (5.4, 9.9) 
Denmark 2000-2014 -3.4 (-7.1, 0.5) 2000-2009 4.6* (0.2, 9.3) 2009-2014 -19.6* (-27.7, -10.6) - - 
Finland 2001-2014 2.8* (1.4, 4.2) 2001-2006 8.7* (5.2, 12.2) 2006-2014 -0.1 (-1.7, 1.5) - - 
France 2000-2014 -6.8* (-9.7, -3.8) 2000-2007 2.7 (-1.8, 7.5) 2007-2014 -15.4* (-19.2, -11.5) - - 
Germany 2000-2014 3.4* (1.8, 5.1) 2000-2003 17.3* (11.1, 23.8) 2003-2007 3.2 (-2.2, 9.0) 2007-2014 0.1 (-1.3, 1.6) 
Hungary 2004-2014 2.1 (-2.7, 7.1) - - - - - - 
Ireland 2000-2014 -2.5 (-4.9, 0.0) - - - - - - 
Italy 2001-2014 -4.8* (-6.5, -2.9) 2001-2008 0.3 (-0.9, 1.6) 2008-2014 -10.7* (-12.1, -9.3) - - 
Latvia 2004-2014 18.8* (3.7, 36.1) - - - - - - 
Lithuania 2001-2014 8.4* (6.1, 10.8) - - - - - - 
Luxembourg 2002-2012 -4.7 (-9.8, 0.6) - - - - - - 
Netherlands 2004-2012 30.7* (14.3, 49.6) 2004-2010 15.3* (2.6, 29.7) 2010-2012 128.6* (14.1, 357.9) - - 
Poland 2005-2014 5.5 (-6.4, 18.8) 2005-2012 19.4* (11.2, 28.2) 2012-2014 -47.4* (-69.1, -10.5) - - 
Portugal 2000-2014 -1.3 (-3.2, 0.7) - - - - - - 
Slovakia 2000-2014 6.2* (1.2, 11.4) 2000-2004 41.8* (18.4, 69.8) 2004-2009 -10.8 (-25.5, 6.8) 2009-2014 14.2 (-0.3, 30.9) 
Slovenia 2004-2014 4.8* (1.9, 7.8) - - - - - - 
Spain 2000-2014 17.8* (10.3, 25.8) 2000-2005 58.9* (31.1, 92.7) 2005-2014 3.4 (-4.4, 11.8) - - 
United Kingdom 2000-2014 -1.9* (-2.7, -1.1) - - - - - - 
Abbreviations: APC: annual percent change; CI: confidence interval. *p-value<0.05 for change in trend. 
  
 Table 3. Joinpoint analysis for Alzheimer’s disease hospital morbidity trends in women in the European Union, 2000-2014. 
 Total study period Period 1 Period 2 Period 3 
  Years APCa (95% CIb) Years APCa (95% CIb) Years APCa (95% CIb) Years APCa (95% CIb) 
European Union 2000-2014 -1.0 (-2.4, 0.5) 2000-2004 6.7* (2.2, 11.5) 2004-2012 -2.0* (-3.8, -0.2) 2012-2014 -11.8 (-23.1, 1.1) 
Austria 2000-2014 -1.2 (-6.6, 4.4) 2000-2002 100.3* (14.8, 249.3) 2002-2014 -6.5* (-9.5, -3.3) - - 
Belgium 2000-2013 10.8* (8.3, 13.3) - - - - - - 
Croatia 2002-2014 -5.6* (-8.4, -2.7) 2002-2012 -8.1* (-11.1, -5.0) 2012-2014 22.3 (-20.2, 87.5) - - 
Cyprus 2005-2013 14.3 (-0.6, 31.3) - - - - - - 
Czech Republic 2000-2014 4.5* (3.8, 5.2) - - - - - - 
Denmark 2000-2014 -1.3 (-4.1, 1.6) 2000-2012 1.4 (-1.5, 4.2) 2012-2014 -29.9 (-56.4, 12.8) - - 
Finland 2001-2014 2.7* (1.4, 4.0) 2001-2007 7.0* (5.1, 8.9) 2007-2014 -0.7 (-2.1, 0.7) - - 
France 2000-2014 -7.1* (-10.5, -3.7) 2000-2007 3.7 (-1.7, 9.4) 2007-2014 -16.8* (-21.2, -12.3) - - 
Germany 2000-2014 3.0* (1.4, 4.6) 2000-2003 16.9* (11.2, 22.8) 2003-2008 2.3 (-0.8, 5.6) 2008-2014 -0.7 (-2.3, 1.0) 
Hungary 2004-2014 -1.3 (-5.8, 3.5) 2004-2008 -14.0 (-26.1, 0.1) 2008-2014 6.8 (-1.5, 15.9) - - 
Ireland 2000-2014 -3.6* (-5.2, -2.0) - - - - - - 
Italy 2001-2014 -5.0* (-6.9, -3.2) 2001-2005 1.0 (-1.2, 3.3) 2005-2009 -2.3 (-5.7, 1.2) 2009-2014 -12.2* (-13.6, -10.8) 
Latvia 2004-2014 21.6* (3.9, 42.3) - - - - - - 
Lithuania 2001-2014 10.6* (7.1, 14.1) 2001-2004 34.5* (17.7, 53.8) 2004-2014 6.7* (4.5, 9.0) - - 
Luxembourg 2002-2012 -6.0* (-8.5, -3.5) - - - - - - 
Netherlands 2004-2012 26.1* (12.3, 41.7) 2004-2010 12.4* (6.1, 19.0) 2010-2012 111.0* (50.6, 195.6) - - 
Poland 2005-2014 5.3 (-6.7, 18.9) 2005-2012 19.4* (9.6, 30.0) 2012-2014 -47.7* (-72.3, -0.9) - - 
Portugal 2000-2014 0.1 (-1.6, 1.9) - - - - - - 
Slovakia 2000-2014 4.8* (0.4, 9.4) 2000-2004 35.0* (18.6, 53.7) 2004-2007 -16.5 (-44.5, 25.8) 2007-2014 6.9* (0.7, 13.5) 
Slovenia 2004-2014 11.5* (7.3, 15.9) 2004-2006 44.0* (14.0, 81.9) 2006-2014 7.4* (4.7, 10.2) - - 
Spain 2000-2014 17.0* (9.1, 25.5) 2000-2002 -6.1 (-29.8, 25.7) 2002-2005 99.8* (49.3, 167.4) 2005-2014 0.1 (-2.5, 2.8) 
United Kingdom 2000-2014 -2.9* (-3.7, -2.0) - - - - - - 
Abbreviations: APC: annual percent change; CI: confidence interval. *p-value<0.05 for change in trend. 
 
  
 Figure 1. Trends in hospital morbidity from Alzheimer’s disease in the entire European Union, 2000-2014. 
 
 Figure 2. Trends in hospital morbidity from Alzheimer’s disease in the member countries of the European Union, 2000-2014. 
 
 Figure legends 
Square (blue): women (age-standardised morbidity rates) 
Circle (red): men (age-standardised morbidity rates) 
Green line: trends in hospital morbidity from Alzheimer’s disease for European women. 
Blue line: trends in hospital morbidity from Alzheimer’s disease for European men.
 Supplemental Data 1. Overall age-standardised hospital morbidity rates in the European Union, 2000-2014. 
 
Countries 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
European Union 42.12 44.94 47.65 51.41 53.88 53.68 52.12 51.68 52.02 50.68 44.10 48.74 46.99 44.03 35.88 
Austria 26.92 106.06 104.32 108.26 126.62 106.75 100.76 103.80 106.02 117.81 99.51 81.09 64.55 56.18 46.74 
Belgium 69.36 74.35 94.63 131.24 143.95 149.61 158.09 164.24 158.26 156.74 - 277.10 264.08 260.03 - 
Croatia - - 23.54 20.89 21.78 23.27 18.52 21.26 15.80 14.21 9.99 15.81 11.76 15.16 18.40 
Cyprus - - - - - 1.62 0.92 1.36 - - 1.10 2.15 2.15 2.71 - 
Czech Republic 63.36 64.76 68.47 69.54 78.45 77.97 74.45 73.51 84.16 87.15 96.84 105.11 112.37 108.19 111.83 
Denmark 5.17 4.67 5.90 6.53 6.33 6.32 7.20 6.35 6.71 6.48 6.07 5.94 5.84 3.96 2.81 
Finland - 217.28 224.19 253.31 253.93 284.25 311.46 329.72 324.01 312.57 311.14 295.52 316.75 311.46 320.76 
France 90.42 62.98 69.12 71.86 89.21 98.73 90.16 81.67 81.67 68.75 49.45 45.14 36.22 31.35 26.71 
Germany 30.67 38.42 43.25 49.34 51.82 53.86 53.61 56.83 56.88 55.62 55.53 57.22 58.21 54.56 54.22 
Hungary - - - - 15.60 18.45 15.50 10.42 9.45 11.93 14.57 13.46 15.28 14.15 15.47 
Ireland 41.00 43.38 47.47 46.54 40.38 36.45 34.48 25.66 34.88 31.52 27.48 26.48 34.60 32.28 28.31 
Italy - 47.74 47.58 51.10 48.72 50.29 49.11 47.95 47.19 44.92 40.30 34.60 31.12 27.66 23.98 
Latvia - - - - 1.72 1.38 0.74 0.97 1.48 2.11 1.82 2.99 1.97 2.37 16.43 
Lithuania - 9.23 9.47 10.51 20.30 18.01 18.69 20.66 23.41 21.31 26.82 30.26 28.30 32.83 28.64 
Luxembourg - - 74.54 75.26 93.54 85.80 59.68 56.82 56.75 57.22 50.28 54.08 44.19 41.02 52.58 
Netherlands - - - - 2.09 2.86 3.14 3.80 4.37 5.51 4.71 7.53 28.81 - - 
Poland - - - - - 15.89 16.25 16.65 23.65 37.00 39.22 37.38 40.62 35.76 11.64 
Portugal 5.83 7.25 6.47 6.65 5.30 6.54 6.06 4.92 5.05 6.23 6.28 5.72 6.54 5.58 6.12 
Slovakia 3.79 4.95 5.40 8.11 13.10 13.05 8.13 8.27 7.34 7.20 7.71 10.23 10.21 - 11.85 
Slovenia - - - - 33.77 36.23 55.58 59.91 56.99 56.52 67.59 76.42 77.65 82.09 82.91 
Spain 2.58 2.98 3.15 3.56 17.37 18.27 19.21 19.83 19.73 19.71 18.66 23.60 24.36 18.33 22.43 
  United Kingdom
  
41.90
  
45.12
  
45.55
  
44.05
  
43.04
  
41.26
  
37.80
  
37.97
  
37.16
  
38.69
  
39.00
  
39.29
  
32.72
  
30.47
  
31.40  
  
 
Supplemental Data 2. Age-standardised hospital morbidity rates in men in the European Union, 2000-2014. 
 
Countries 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
European Union 38.40 41.54 43.60 47.65 48.79 48.78 48.52 48.19 47.76 46.45 41.13 45.94 44.59 41.68 34.74 
Austria 26.14 95.38 104.67 109.74 128.77 101.93 114.23 107.13 108.05 113.57 92.34 76.70 62.65 52.56 43.04 
Belgium 69.33 70.20 93.78 126.74 134.18 144.67 145.81 152.01 146.84 141.27 - 241.72 238.21 231.42 - 
Croatia - - 18.92 12.81 17.70 19.07 16.09 15.67 13.63 11.95 7.23 14.41 12.32 16.22 17.44 
Cyprus - - - - - 2.35 1.28 1.89 - - 1.58 1.96 0.91 4.03 - 
Czech Republic 54.73 59.01 61.16 61.87 69.72 67.22 62.94 61.46 68.68 75.47 81.04 91.25 99.78 93.05 102.45 
Denmark 5.45 6.04 7.14 6.45 8.76 6.59 7.28 8.84 8.27 8.27 6.42 6.00 6.37 3.33 2.71 
Finland - 232.41 226.82 274.06 279.60 302.03 345.55 358.98 334.80 333.53 325.84 314.47 339.34 341.02 345.39 
France 78.66 56.95 61.39 63.69 75.69 85.01 78.41 71.20 68.40 56.91 43.48 42.75 33.53 28.46 23.84 
Germany 28.99 36.98 40.54 48.38 49.42 51.32 52.42 55.12 54.69 54.38 55.16 56.05 57.65 53.71 54.29 
Hungary - - - - 12.86 16.74 14.29 9.20 8.77 12.61 15.33 16.70 14.10 15.99 14.82 
Ireland 34.03 34.29 45.77 38.63 31.16 23.90 29.49 20.22 30.91 26.24 21.29 25.35 34.63 26.15 27.76 
Italy - 40.60 41.12 45.50 43.12 42.89 43.79 43.15 40.75 38.90 35.56 30.21 27.25 24.51 21.94 
Latvia - - - - 0.28 2.15 1.04 1.58 1.62 2.03 0.91 1.38 2.13 2.38 8.76 
Lithuania - 10.03 11.00 12.75 14.21 12.12 16.84 23.79 22.70 18.60 25.87 24.76 24.91 29.91 24.79 
Luxembourg - - 71.20 55.68 109.26 112.44 57.04 61.18 68.27 60.30 63.50 46.42 48.43 - - 
Netherlands - - - - 1.53 2.55 3.36 3.27 3.45 5.36 4.30 7.22 30.55 - - 
Poland - - - - - 14.11 14.79 16.54 21.46 33.87 37.23 34.90 36.54 32.71 10.92 
Portugal 7.63 6.23 6.33 7.36 5.14 7.34 5.39 4.39 5.06 6.12 5.61 5.16 6.67 5.83 5.89 
Slovakia 3.49 3.52 5.62 9.74 11.68 10.72 9.87 10.23 6.30 6.52 7.77 10.41 10.81 - 12.20 
Slovenia - - - - 49.29 54.58 57.03 75.45 55.03 53.52 60.36 64.99 83.98 83.99 80.34 
Spain 1.59 3.25 3.41 3.26 14.10 15.59 16.65 17.15 17.83 17.65 16.33 22.93 22.82 16.35 21.04 
  United Kingdom
  
39.72
  
45.08
  
43.90
  
42.04
  
40.27
  
39.99
  
36.44
  
36.97
  
38.79
  
38.07
  
38.73
  
39.66
  
33.09
  
32.05
  
31.58  
  
 
Supplemental Data 3. Age-standardised hospital morbidity rates in women in the European Union, 2000-2014. 
 
Countries 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
European Union 44.15 47.06 50.12 53.81 57.01 56.61 54.35 53.83 54.61 53.19 45.88 50.48 48.51 45.66 36.66 
Austria 27.27 112.43 104.79 108.37 126.09 110.01 94.95 101.74 104.96 118.94 103.86 84.36 65.90 58.56 48.85 
Belgium 70.58 77.15 96.78 134.62 151.74 154.67 165.90 172.66 166.92 166.72 - 298.69 280.36 279.62 - 
Croatia - - 26.38 24.64 24.41 25.62 19.92 22.88 17.15 15.15 12.21 16.34 11.10 14.83 18.64 
Cyprus - - - - - 0.97 0.75 0.89 - - 0.82 2.32 3.13 1.64 - 
Czech Republic 67.95 67.76 72.55 73.44 83.50 83.81 81.04 80.34 93.01 93.65 105.61 113.11 120.19 116.33 117.12 
Denmark 5.29 3.92 5.05 6.48 4.94 5.98 7.15 4.85 6.05 5.47 5.72 5.83 5.40 4.41 2.86 
Finland - 209.89 222.02 244.40 242.31 277.56 295.92 318.39 319.48 302.90 303.74 287.95 305.43 297.06 310.89 
France 96.92 66.88 73.93 77.08 98.09 106.92 97.54 88.38 89.84 75.95 52.94 46.35 37.87 33.33 28.57 
Germany 31.52 39.13 44.76 50.13 53.09 55.29 54.04 57.78 58.05 56.22 56.05 58.18 58.86 55.51 54.62 
Hungary - - - - 17.32 19.46 16.41 11.04 9.88 11.62 14.11 12.19 16.17 13.44 15.87 
Ireland 44.35 49.14 49.42 52.44 46.60 45.00 37.78 29.93 38.57 35.68 32.29 27.61 35.67 37.46 29.06 
Italy - 52.36 51.79 54.69 52.29 55.05 52.72 51.26 51.40 48.99 43.58 37.71 33.69 29.86 25.37 
Latvia - - - - 2.28 0.98 0.68 0.60 1.24 2.06 2.19 3.64 1.71 2.57 19.44 
Lithuania - 8.66 9.09 9.87 23.04 20.35 19.81 19.45 23.88 22.77 27.66 32.22 30.12 34.69 30.72 
Luxembourg - - 73.70 87.70 88.58 73.44 62.43 57.70 53.69 56.17 45.34 59.79 43.75 - - 
Netherlands - - - - 2.50 3.08 2.93 4.03 4.97 5.53 5.00 7.98 28.15 - - 
Poland - - - - - 16.71 17.07 16.74 24.94 38.38 40.53 38.42 42.86 37.36 12.05 
Portugal 4.82 7.88 6.50 6.29 5.44 6.17 6.44 5.34 5.02 6.50 6.77 6.16 6.55 5.54 6.43 
Slovakia 3.95 5.93 5.14 7.29 13.43 14.29 7.47 7.42 7.93 7.80 7.59 10.13 10.19 - 11.62 
Slovenia - - - - 26.87 29.46 55.66 54.89 56.23 59.74 70.93 83.15 76.28 83.11 86.34 
Spain 3.13 2.86 2.92 3.80 19.10 19.67 20.55 21.19 20.67 20.80 19.78 23.97 25.19 19.58 23.33 
  United Kingdom
  
43.37
  
45.49
  
46.64
  
45.80
  
45.11
  
42.42
  
39.25
  
38.81
  
36.26
  
39.23
  
38.99
  
39.04
  
32.29
  
29.37
  
31.09  
  
 
Supplemental Data 4. Joinpoint analysis for dementia hospital morbidity trends in the European Union, 2000-2014. 
 
Total study period Period 1 Period 2 Period 3 
 Years APC
a (95% CI
b
) Years APC
a (95% CI
b
) Years APC
a (95% CI
b
) Years APC
a (95% CI
b
) 
European Union 2000-2014 -3.9* (-4.2, -3.7) - - - - - - 
Austria 2000-2014 -1.7* (-3.3, -0.1) 2000-2002 -19.9 (-36.3, 0.8) 2002-2014 -0.2 (-1.5, 1.2) - - 
Belgium 2000-2013 -8.3* (-10.4, -6.3) 2000-2004 -5.3* (-7.5, -2.9) 2004-2007 -19.8* (-25.7, -13.4) 2007-2013 -1.3 (-2.5, 0.0) 
Croatia 2002-2014 -0.1 (-1.1, 0.8) - - - - - - 
Cyprus 2005-2013 89.0* (6.1, 236.5) - - - - - - 
Czech Republic 2000-2014 -1.4* (-2.0, -0.8) 2000-2011 -0.7* (-1.4, -0.1) 2011-2014 -5.7* (-10.2, -1.0) - - 
Denmark 2000-2014 -4.8* (-6.5, -3.2) 2000-2002 19.8* (0.4, 43.0) 2002-2014 -6.5* (-7.5, -5.5) - - 
Finland 2001-2014 -4.2* (-4.5, -3.8) - - - - - - 
France 2000-2014 -0.7 (-1.7, 0.2) 2000-2008 1.8* (1.0, 2.6) 2008-2014 -4.4* (-5.6, -3.2) - - 
Germany 2000-2014 -7.1* (-7.5, -6.6) 2000-2007 -8.2* (-9.3, -7.1) 2007-2014 -5.9* (-7.0, -4.7) - - 
Hungary 2004-2014 -4.3* (-5.6, -3.1) - - - - - - 
Ireland 2000-2014 2.9* (0.7, 5.0) - - - - - - 
Italy 2001-2014 -7.4* (-7.9, -6.9) 2001-2004 -11.1* (-13.6, -8.6) 2004-2014 -6.7* (-7.1, -6.3) - - 
Latvia 2004-2014 4.9* (2.0, 7.8) - - - - - - 
Lithuania 2001-2014 -9.2* (-11.3, -7.0) - - - - - - 
Luxembourg 2002-2014 -2.2* (-3.2, -1.1) - - - - - - 
Netherlands 2004-2012 -4.3* (-7.2, -1.3) 2004-2010 -1.1 (-3.4, 1.2) 2010-2012 -17.4* (-28.0, -5.3) - - 
Poland 2005-2014 -0.9 (-2.3, 0.6) - - - - - - 
Portugal 2000-2014 -3.6* (-5.0, -2.2) 2000-2003 -7.7* (-14.3, -0.6) 2003-2008 2.4 (-2.2, 7.4) 2008-2014 -8.9* (-11.1, -6.6) 
Slovakia 2000-2014 -0.3 (-1.0, 0.4) - - - - - - 
Slovenia 2004-2014 0.7 (-1.1, 2.6) 2004-2006 12.9 (-8.3, 38.9) 2006-2014 -0.9 (-3.1, 1.4) - - 
Spain 2000-2014 -4.2* (-4.9, -3.5) - - - - - - 
United Kingdom 2000-2014 -4.8* (-5.6, -4.0) 2000-2004 -2.4 (-5.3, 0.6) 2004-2007 -11.2* (-19.2, -2.4) 2007-2014 -2.0* (-3.3, -0.8) 
Abbreviations: APC: annual percent change; CI: confidence interval. *p-value<0.05 for change in trend. 
  
Supplemental Data 5. Trends in hospital morbidity from dementia in the entire European Union, 2000-2014. 
 
 
  
Supplemental Data 6. Trends in hospital morbidity from dementia in the member countries of the European Union, 2000-2014. 
